S3-E10.4 – Value of Screening for NAFLD as NASH Prevalence Grows
As NASH Prevalence grows, how many patients should we be screening for NAFLD and at what age should we start?
February 13, 2022
As NASH Prevalence grows, how many patients should we be screening for NAFLD and at what age should we start?
As NAFLD prevalence grows, what can we learn from US and UK data and clinical experience about the value of early NASH diagnosis and education for Fatty Liver patients?
Fatty Liver Researcher and endocrinology key opinion leader Ken Cusi discusses the high levels of NAFLD prevalence and fibrosis among
